期刊文献+

肝硬化患者骨密度的改变 被引量:5

Changes in bone mineral density in patients with liver cirrhosis
暂未订购
导出
摘要 目的:探讨肝硬化患者腰椎、股骨骨密度的改变以及肝功能、血钙、血磷、体质量指数(BMI)等相关因素的关系.方法:102名受试者分为两大组:肝硬化组60例,其中Child-Pugh A级22例,B级18例,C级20例;正常对照组42例,两组均同步检测其腰椎、股骨骨密度Ca2+、P3+及胆碱脂酶.另外收集肝硬化患者的年龄、BMI以及肝功能等指标.结果:肝硬化组腰椎、股骨骨密度均较对照组明显降低(P<0.05或0.01).Child C腰椎骨密度较对照组、Child A级差异明显,统计学有显著性差异(0.851±0.207vs1.070±0.22,1.036±0.192,均P<0.05).肝硬化患者的腰椎、股骨骨密度均与BMI有直线相关性(r=2.3,2.418,均P<0.05),同时腰椎骨密度还与胆碱酯酶有直线相关性(r=2.734,P<0.05).结论:慢性肝硬化患者腰椎骨密度的改变比股骨明显;胆碱酯酶反应了肝脏的储备能力与肝脏损害的程度,一定程度上可预测肝硬化腰椎骨密度是否改变. AIM:To observe changes in bone mineral density (BMD) of the femur and lumbar spine in patients with liver cirrhosis and analyze factors potentially correlated with such changes. METHODS:Sixty liver cirrhosis patients,of which 22 had Child-Pugh A liver function,18 had Child-Pugh B,and 20 had Child-Pugh C,and 42 healthy volunteers were included in the study. The BMD of the femur and lumbar spine as well as serum calcium (Ca2+),inorganic phosphate (P3+) and cholinesterase (CHE) were simultaneously measured in both groups. Other parameters such as age,body mass index (BMI) and liver function were also recorded. RESULTS:The BMD of the femur and lumbar spine was significantly lower in liver cirrhosis patients than in normal controls (P〈0.05 and 0.01,respectively). The BMD of the lumbar spine was significantly lower in patients with ChildPugh A liver function than in normal controls and patients with Child-Pugh C liver function (0.851 ± 0.207 vs 1.070 ± 022 and 1.036 ± 0.192,respectively; both P〈0.05). A linear correlation was noted between the BMD of the femur and lumbar spine and BMI (r = 2.3 and 2.418,respectively; both P〈0.05) as well as between lumbar BMD and CHE (r = 2.734,P〈0.05). CONCLUSION:The change in the BMD of the lumbar spine was more significant than that in the BMD of the femur in patients with liver cirrhosis. CHE may predict,to some extent,the change in lumbar BMD.
出处 《世界华人消化杂志》 CAS 北大核心 2009年第27期2850-2853,共4页 World Chinese Journal of Digestology
关键词 肝硬化 骨密度 血钙 胆碱酯酶 Liver cirrhosis Bone mineral density Serum calcium Cholinesterase
  • 相关文献

参考文献11

二级参考文献59

  • 1谢晶,杜靖远,沈霖,杨艳萍,周丕祺.体重和身高对峰值骨量的影响[J].中国骨质疏松杂志,1997,3(1):27-28. 被引量:16
  • 2陈金标,秦林林,张卫,葛崇华,马海波,肖艳霞.体重体成分与骨密度的关系[J].中国骨质疏松杂志,1997,3(2):15-18. 被引量:52
  • 3李明.饮酒与骨骼[J].国外医学(医学地理分册),1995,16(4):170-172. 被引量:8
  • 4陈晓琴 周力 等.肝脏病时血清胆碱酯酶测定的意义[J].国际华人医学杂志,2000,3(1):17-17.
  • 5[7]May H, Murphy S, Khaw KT. Age-associated bone loss in men and women and its relationship to weight. Ageing, 1994,23:235.
  • 6[7]Sokhi RP,Anantharaju A,Kondaveeti R,et al.Bone mineral density among cirrhotic patients awaiting liver transplantation[J].Liver Transpl,2004,10(1):648-653.
  • 7[8]Crawford BA,Kam C,Donaghy AJ,et al.The heterogeneity of bone disease in cirrhosis:a multivariate analysis[J].Osteoporos Int,2003,14(2):987-994.
  • 8[9]Collier JD,Ninkovic M,Compston JE.Guidelines on the management of osteoporosis associated with chronic liver disease[J].Gut,2002,50(Suppl 1):i1-i9.
  • 9Takahashi T,Wada T,Mori M,et al. Lab Invest, 1996;74(4):827--834.
  • 10Wolfhagen FH,Van Buuren HR,Vleggsar FP,et al. Baillieres Best Pract Res Clin Gasvroenterol, 2000; 14 (4): 629 - 641.

共引文献66

同被引文献29

  • 1安纪红,王勇.肝硬化患者血清钙、磷、甲状旁腺素及骨密度指标的变化与Child-Pugh分级的关系[J].传染病信息,2007,20(2):107-108. 被引量:2
  • 2Chinese Society of Hepatology and Chinese Society of Infectious Diseases,Chinese Medical Association. 42 Dongsi Xidajie,Beijing 100710,China.慢性乙型肝炎防治指南[J].中华肝脏病杂志,2005,13(12):881-891. 被引量:1927
  • 3中国老年学学会骨质疏松委员会“指南”专家委员会.中国人群骨质疏松诊疗指南[J].中国骨质疏松杂志,2004,12(10):567-613.
  • 4Assessment of fracture risk and its application to screening for postm- enopausal osteoporssis: synopsi [ J ] . Report of a WHO Study Group. World Health Organ Tech Rep Ser 1994, 843 : 1 - 129.
  • 5Lewiecki EM. Clinical applications of bone density testing orosteo- porosis. Minerva Med, 2005,96(5):317-330.
  • 6Bossy E, Talmant M, Peyrin F, et al. An in vitro study of the ultra- sonic axial transmission technique at the radius: 1-MHz velocity measurements are sensitive to both mineralization and intracortical porosity. J Bone Miner Res, 2004,19(9):1548-1556.
  • 7Ambrogini E,Toraldo G,Marcocci G.Post-menopausal osteoporosis:is it an autoimmune disease[J].J Endocrinol lnvest,2005,289(10):43-47.
  • 8Pfeilschifter J.Role of cytokines in postmenopausal bone loss [J].Curr Osteoporos ReP,2003,1(2):53-58.
  • 9李东,薛延,郭三巧,毛玉江.定量超声在预测骨折风险上的价值[J].山东医药,2009,49(8):67-68. 被引量:2
  • 10李晓虹,杨蒲芳,陈范嵘,胡海强.IGF-1、TNF-α及IL-8对男性肝硬化患者骨代谢的影响[J].临床消化病杂志,2009,21(3):153-155. 被引量:5

引证文献5

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部